Financial results - PHARMAFARM MEDICAL S.R.L.

Financial Summary - Pharmafarm Medical S.r.l.
Unique identification code: 43015609
Registration number: J3/1380/2020
Nace: 4773
Sales - Ron
7.511
Net Profit - Ron
-133.953
Employees
Open Account
Company Pharmafarm Medical S.r.l. with Fiscal Code 43015609 recorded a turnover of 2024 of 7.511, with a net profit of -133.953 and having an average number of employees of - . The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmafarm Medical S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 0 4.288 9.960 17.846 7.511
Total Income - EUR - - - - - 0 33.712 50.577 17.846 7.511
Total Expenses - EUR - - - - - 108 41.065 89.695 81.043 141.464
Gross Profit/Loss - EUR - - - - - -108 -7.352 -39.118 -63.197 -133.953
Net Profit/Loss - EUR - - - - - -108 -8.364 -40.635 -63.197 -133.953
Employees - - - - - 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -57.7%, from 17.846 euro in the year 2023, to 7.511 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmafarm Medical S.r.l.

Rating financiar

Financial Rating -
PHARMAFARM MEDICAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmafarm Medical S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmafarm Medical S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmafarm Medical S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmafarm Medical S.r.l. - CUI 43015609

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 19.929 6.180 37.542 37.428 64.091
Current Assets - - - - - 6.056 26.672 38.176 77.774 102.562
Inventories - - - - - 0 3.723 4.142 6.122 9.861
Receivables - - - - - 3.789 8.847 30.438 59.269 88.079
Cash - - - - - 2.267 14.102 3.596 12.383 4.621
Shareholders Funds - - - - - 1.960 -6.447 -47.103 -110.156 -243.501
Social Capital - - - - - 2.067 2.022 2.028 2.022 2.010
Debts - - - - - 24.026 39.299 122.821 225.359 410.153
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 102.562 euro in 2024 which includes Inventories of 9.861 euro, Receivables of 88.079 euro and cash availability of 4.621 euro.
The company's Equity was valued at -243.501 euro, while total Liabilities amounted to 410.153 euro. Equity decreased by -133.960 euro, from -110.156 euro in 2023, to -243.501 in 2024.

Risk Reports Prices

Reviews - Pharmafarm Medical S.r.l.

Comments - Pharmafarm Medical S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.